Invention Grant
US08153668B2 Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate
失效
（S）-1-四氢呋喃-3-基-3-（3-（3-甲氧基-4-（恶唑-5-基）苯基）脲基）苄基氨基甲酸酯的多晶型
- Patent Title: Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate
- Patent Title (中): （S）-1-四氢呋喃-3-基-3-（3-（3-甲氧基-4-（恶唑-5-基）苯基）脲基）苄基氨基甲酸酯的多晶型
-
Application No.: US12555203Application Date: 2009-09-08
-
Publication No.: US08153668B2Publication Date: 2012-04-10
- Inventor: Todd Blythe , Alex Eberlin , Michael Hurrey , David Jonaitis , Philip Nyce , Stephan Parent , John Snoonian
- Applicant: Todd Blythe , Alex Eberlin , Michael Hurrey , David Jonaitis , Philip Nyce , Stephan Parent , John Snoonian
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Michael C. Badia
- Main IPC: A61K31/422
- IPC: A61K31/422
Abstract:
The present invention relates to polymorphic forms of (S)-tetrahydrofuran-3-yl 3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate, processes therein, pharmaceutical compositions thereof, and uses therewith.
Public/Granted literature
Information query
IPC分类:
